US Broker Ratings

Apellis Pharmaceuticals (APLS) Stock Analysis: Exploring a 68.77% Upside Potential in Biotechnology

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands at the forefront of the biotechnology sector, with a market capitalization of $2.56 billion. Headquartered in Waltham, Massachusetts, this commercial-stage..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 50.93% Upside Potential in the Medical Device Sector

UFP Technologies, Inc. (UFPT), a key player in the medical device sector, is drawing significant attention from investors due to its robust market positioning and impressive..

Sotera Health Company (SHC) Stock Analysis: A 42% Potential Upside Beckons Investors

Sotera Health Company (NASDAQ: SHC) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Ardent Health, Inc. (ARDT) Stock Analysis: Navigating a 39.77% Potential Upside in the Healthcare Sector

Ardent Health, Inc. (ARDT) is garnering attention within the healthcare sector for its potential upside of nearly 40%, according to recent analyst ratings. Operating in the..

Alvotech (ALVO) Stock Analysis: Is a 368% Upside Within Reach for This Biosimilar Pioneer?

Alvotech (NASDAQ: ALVO) is steadily carving out its niche in the healthcare sector, focusing on the development and manufacturing of biosimilar medicines. With a market capitalization..

Scholar Rock Holding Corporation (SRRK): Investor Outlook on a Biotech Innovator with 24.51% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is increasingly becoming a focal point for investors looking to capitalize on the innovative strides being made in the biotechnology..

Immunovant, Inc. (IMVT) Stock Analysis: Potential 55% Upside Sparks Investor Interest

Immunovant, Inc. (NASDAQ: IMVT), a promising player in the biotechnology sector, has captured investor attention with its potential for significant upside. With a market capitalization of..

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Gem with 18% Potential Upside

Belite Bio, Inc (NASDAQ: BLTE) stands as a promising prospect in the biotechnology sector, captivating investor interest with its robust clinical pipeline and a potential upside..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 62% Upside Potential in the Biotechnology Sector

Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology sector, is capturing investor attention with its promising growth prospects and robust market position. With a..

LivaNova PLC (LIVN): Investor Outlook on Strong Revenue Growth Amidst Medical Device Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling case for investors seeking exposure to..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 30% Potential Upside in Biotechnology

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology firm based in Zug, Switzerland, is making waves in the healthcare sector. Specializing in innovative treatments for inflammatory skin..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Healthcare Genomics Leader with 65.77% Potential Upside

GeneDx Holdings Corp. (NASDAQ: WGS) is capturing investor attention across the healthcare sector with its robust position in the diagnostics and research industry. With a market..

Amneal Pharmaceuticals, Inc. (AMRX): Investor Outlook Highlights 26.79% Potential Upside

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a prominent player in the healthcare sector focused on specialty and generic drug manufacturing, stands as an intriguing prospect for investors..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Navigating a 11.56% Potential Upside in the Biotech Arena

Investors with an appetite for potential growth in the biotech sector should consider Protagonist Therapeutics, Inc. (NASDAQ: PTGX). With a market capitalization of $6.17 billion, this..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A Look at Its 150% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a beacon of innovation in the biotechnology industry, particularly in the niche of rare and ultra-rare genetic diseases. With..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Exploring a 28.66% Upside Potential in the Healthcare Robotics Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is carving a niche for itself in the healthcare sector, particularly within the medical devices industry. This San Jose-based company is..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Uncovering a 37.15% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is making waves in the biotechnology sector, offering investors a tantalizing opportunity with its potential upside of 37.15%. As a commercial-stage..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a 13.40% Upside with Strong Buy Ratings

Warby Parker Inc. (WRBY), a notable player in the healthcare sector, is garnering attention with its promising investment outlook. Known for its innovative approach to selling..

Concentra Group Holdings Parent (CON): A Promising Investment with 28% Upside Potential

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a key player in the healthcare sector, is making waves among investors with its strong foothold in the medical..

ImmunityBio, Inc. (IBRX) Stock Analysis: Eyeing an 80% Potential Upside in the Biotech Arena

In the ever-evolving landscape of biotechnology, ImmunityBio, Inc. (NASDAQ: IBRX) stands out with its ambitious innovations in immunotherapy. Based in San Diego, California, ImmunityBio is at..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds